Follow The Filings

STAA STAAR Surgical

STAAR Surgical earnings company data as of 6:51 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.06 — —
Rev — — —

Insider trades

Open-market buys and sales by STAA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All STAA insider trades
  • $62.8M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Broadwood Partners, L.P. Director, +2 joint filers
    Buy
    $12.3M 670,213 shares at $18.30
    Traded Mar 11–13 Filed Mar 13
    ↗
  2. Broadwood Partners, L.P. 10% owner, +2 joint filers
    Buy
    $606K 27,485 shares at $22.05
    Traded Jan 9 Filed Jan 13
    ↗
  3. Broadwood Partners, L.P. 10% owner, +2 joint filers
    Buy
    $8.8M 406,653 shares at $21.68
    Traded Jan 6–8 Filed Jan 8
    ↗
  4. Broadwood Partners, L.P. 10% owner, +2 joint filers
    Buy
    $41.1M 1,500,000 shares at $27.37
    Traded Nov 19–21 Filed Nov 21, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 share withholdings for taxes, 19 option exercises, and 11 stock grants.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K/A 5.02,7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.